Medical Educational Resource
We're accelerating the delivery of treatments and cures.
SPINRAZA® (nusinersen) High Dose Regimen for Patients with Spinal Muscular Atrophy
Activity Snapshot
Activity Type:
Live, Virtual Webinar
Release Date:
Wednesday, August 5, 2026
Activity Overview:
9:00 AM in Arizona
This webinar provides an overview of the SPINRAZA High Dose regimen supported by the DEVOTE clinical trial program, including study design, scientific rationale, and dosing approach. It highlights efficacy outcomes in treatment‑naïve patients and functional changes in treatment‑experienced patients, alongside a review of the safety profile.
